Bruker Corporation Acquires Tornado Spectral Systems Inc.

Bruker Corporation Acquires Spectral Instruments Imaging

February 6, 2024

Medical Devices

Bruker Corporation has acquired Spectral Instruments Imaging LLC, a Tucson-based maker of preclinical in‑vivo optical imaging systems, to broaden Bruker BioSpin's preclinical imaging portfolio. Financial terms were not disclosed; SII generated over $10 million in revenue in 2023 and will expand Bruker's capabilities in bioluminescence, fluorescence and X‑ray preclinical imaging.

Thermo Fisher Scientific Acquires MarqMetrix

June 21, 2023

Medical Devices

Thermo Fisher Scientific has completed its acquisition of MarqMetrix, a Seattle-based developer of Raman-based in-line spectroscopy and Process Analytical Technology (PAT). The deal adds Raman-based in-line PAT capabilities to Thermo Fisher’s Analytical Instruments segment; terms were not disclosed.

Bruker Corporation Acquires Optimal Industrial Automation and Technologies

April 5, 2022

Pharmaceuticals

Bruker Corporation acquired UK-based Optimal Industrial Automation and Technologies, a provider of pharma and biopharma process analytical technology (PAT), manufacturing automation and QA software (including the synTQ platform). The acquisition strengthens Bruker's biopharma manufacturing automation and PAT software capabilities to complement its instrumentation portfolio and accelerate integrated solutions for pharmaceutical and biotech customers.

Bruker Corporation Acquires ZONTAL Inc.

May 8, 2023

Software

Bruker Corporation has closed the acquisition of ZONTAL Inc., a provider of a GxP-compliant life-sciences data platform, to strengthen Bruker BioSpin's Integrated Data Solutions (IDS) software portfolio. The deal (terms not disclosed) will integrate ZONTAL's vendor-agnostic laboratory and process data management capabilities with Bruker's Mestrelab, Arxspan and Optimal offerings to accelerate digital laboratory transformation for biopharma and life-science customers; ZONTAL expected 2023 revenues of greater than $5 million.

Bruker Corporation Acquires Remaining Stake in TOFWERK AG

January 8, 2026

Manufacturing

Bruker Corporation acquired the remaining 60% ownership stake in TOFWERK AG, consolidating its ownership to 100%. The acquisition brings TOFWERK's compact, ultra-fast time-of-flight mass spectrometry technology and ~130 employees into Bruker's portfolio to expand capabilities and address applied markets such as air quality, semiconductor cleanroom monitoring, and food/flavors testing.

Bruker Corporation Acquires Canopy Biosciences, LLC

September 11, 2020

Biotechnology

Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.